Calamos Advisors LLC Eli Lilly & CO Transaction History

Calamos Advisors LLC

$16.1 Billion
Q3 2024

A detailed history of Calamos Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Calamos Advisors LLC holds 288,543 shares of LLY stock, worth $217 Million. This represents 1.59% of its overall portfolio holdings.

Number of Shares

288,543

Previous 331,402 12.93%

Holding current value

$217 Million

Previous $300 Million 14.8%

% of portfolio

1.59%

Previous 1.91%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$772.14 - $960.02 $33.1 Million - $41.1 Million	-42,859 Reduced 12.93%	288,543 $256 Million
Q2 2024 Jul 25, 2024	SELL	$724.87 - $909.04 $4.59 Million - $5.76 Million	-6,332 Reduced 1.87%	331,402 $300 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $21.4 Million - $28.6 Million	-36,110 Reduced 9.66%	337,734 $263 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $1.52 Million - $1.79 Million	-2,892 Reduced 0.77%	373,844 $218 Million
Q3 2023 Oct 25, 2023	SELL	$434.7 - $599.3 $4.4 Million - $6.06 Million	-10,119 Reduced 2.62%	376,736 $202 Million
Q2 2023 Jul 28, 2023	SELL	$350.74 - $468.98 $9.86 Million - $13.2 Million	-28,107 Reduced 6.77%	386,855 $181 Million
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $10.6 Million - $12.4 Million	-33,993 Reduced 7.57%	414,962 $143 Million
Q4 2022 Jan 25, 2023	SELL	$321.55 - $374.67 $17.3 Million - $20.2 Million	-53,957 Reduced 10.73%	448,955 $0
Q3 2022 Oct 24, 2022	BUY	$296.48 - $337.87 $1.89 Million - $2.16 Million	6,388 Added 1.29%	502,912 $163 Million
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $1.1 Million - $1.29 Million	-3,941 Reduced 0.79%	496,524 $161 Million
Q1 2022 May 03, 2022	BUY	$234.69 - $291.66 $3.3 Million - $4.11 Million	14,078 Added 2.89%	500,465 $143 Million
Q4 2021 Feb 01, 2022	BUY	$224.85 - $279.04 $6.31 Million - $7.82 Million	28,041 Added 6.12%	486,387 $134 Million
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $1.77 Million - $2.17 Million	-7,972 Reduced 1.71%	458,346 $106 Million
Q2 2021 Jul 22, 2021	BUY	$180.55 - $233.54 $12.2 Million - $15.8 Million	67,739 Added 17.0%	466,318 $107 Million
Q1 2021 Apr 12, 2021	BUY	$164.32 - $212.72 $9.24 Million - $12 Million	56,221 Added 16.42%	398,579 $74.5 Million
Q4 2020 Jan 27, 2021	SELL	$130.46 - $172.63 $2.3 Million - $3.04 Million	-17,617 Reduced 4.89%	342,358 $57.8 Million
Q3 2020 Oct 26, 2020	BUY	$146.22 - $169.13 $2.65 Million - $3.07 Million	18,125 Added 5.3%	359,975 $53.3 Million
Q2 2020 Jul 27, 2020	BUY	$136.42 - $164.18 $12 Million - $14.5 Million	88,227 Added 34.79%	341,850 $56.1 Million
Q1 2020 Apr 28, 2020	SELL	$119.05 - $147.35 $1.4 Million - $1.73 Million	-11,751 Reduced 4.43%	253,623 $35.2 Million
Q4 2019 Jan 15, 2020	SELL	$106.92 - $132.43 $275,532 - $341,272	-2,577 Reduced 0.96%	265,374 $34.9 Million
Q3 2019 Oct 21, 2019	SELL	$106.79 - $116.16 $1.47 Million - $1.6 Million	-13,782 Reduced 4.89%	267,951 $30 Million
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $648,786 - $757,297	5,856 Added 2.12%	281,733 $31.2 Million
Q1 2019 Apr 12, 2019	BUY	$111.31 - $131.02 $12,466 - $14,674	112 Added 0.04%	275,877 $35.8 Million
Q4 2018 Jan 24, 2019	BUY	$105.9 - $118.64 $2.15 Million - $2.41 Million	20,341 Added 7.96%	275,765 $31.9 Million
Q3 2018 Oct 22, 2018	BUY	$85.86 - $107.31 $587,368 - $734,107	6,841 Added 2.75%	255,424 $27.4 Million
Q2 2018 Jul 17, 2018	BUY	$75.7 - $86.88 $1.01 Million - $1.16 Million	13,311 Added 5.66%	248,583 $21.2 Million
Q1 2018 Apr 13, 2018	BUY	$74.21 - $87.6 $350,939 - $414,260	4,729 Added 2.05%	235,272 $18.2 Million
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $13.7 Million - $14.7 Million	-167,586 Reduced 42.09%	230,543 $19.5 Million
Q3 2017 Oct 25, 2017	BUY	$77.07 - $85.54 $153,985 - $170,908	1,998 Added 0.5%	398,129 $34.1 Million
Q2 2017 Aug 09, 2017	BUY	N/A	396,131	396,131 $32.6 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Account

Calamos Advisors LLC Eli Lilly & CO Transaction History